Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte

COLLEGIUM PHARMACEUTICAL, INC

All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.
Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.
Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.
Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders at the 2026-05-14 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 1 : Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers at the 2026-05-14 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 2: Approval of, on an advisory basis, the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 3 : Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

Browse all shareholder votes →

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR

accession 0001104659-26-062536

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.